NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.